Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Jun 28, 2026
SIGA TECHNOLOGIES INC (SIGA)
A forensic read on SIGA TECHNOLOGIES INC built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
B · Sound & dependable
Forensic grade
Safe
Financial health
16.0
Altman Z-score
Clean
Earnings quality
3
Forensic signals
13.9
P / E (ttm)
10.6%
ROE
$281M
Market cap
15.39%
Dividend yield
SIGA TECHNOLOGIES INC earns a B (Sound & dependable) forensic quality grade, and its Altman Z-score is 16.0, placing it in the Safe zone. 3 forensic signals were flagged in its latest SEC filings, led by inventory days.
What the filings flag
603dInventory days.Days inventory outstanding moved from 578 to 603 FY2024→FY2025 (against cost of goods sold; inventory -1% vs -5% in cost of sales). Inventory is building a little faster than sales — watch for markdowns.
100% of FCFShareholder returns.Returned $43M to shareholders (buybacks + dividends) in FY2025 — 100% of free cash flow. Right at the limit of what free cash flow covers — little room before it's funded by debt or the balance sheet.
-2%Dividend — cut.The payout was CUT ~2% in FY2023 (from FY2022). It still returns some cash, but it is NOT the dependable, rising dividend an unbroken streak implies — weigh the cut when judging reliability.
Key fundamentals
Net Margin24.6%
Debt / Equity0.00x
Free Cash Flow$43.1M
Latest Revenue$94.6M
Return on Equity11.7%
Revenue Growth YoY-31.8%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on SIGA TECHNOLOGIES INC:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about SIGA's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown